Assignee
COUNCIL QUEENSLAND INST MEDICAL RES
AU·10 granted patents·45 pending applications·3 citations·filing 2013–2025
Top patents by PatentIndex Score
55 records- 0180US2024156953A1Human herpesvirus immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2023·Application pending·0 cites
- 0280US2025116669A1Determining a Cancer PrognosisCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2024·Application pending·0 cites
- 0378US11065329B2Human herpesvirus immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2018·Granted Jul 20, 2021·1 cites·24 claims
- 0478US2024418705A1Cellular populations and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2024·Application pending·0 cites
- 0574US2025127874A1Cmv epitopesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2024·Application pending·0 cites
- 0674US2023324369A1Cellular populations and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2023·Application pending·0 cites
- 0773US9901632B2Human herpesvirus immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2013·Granted Feb 27, 2018·2 cites·22 claims
- 0872US11896665B2Human herpesvirus immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Granted Feb 13, 2024·0 cites·19 claims
- 0970US2023068154A1Multivirus-specific t cell immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 1070US2022409662A1Methods of treating autoimmune disease using allogeneic t cellsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 1168US2025383345A1Methods and agents for determining patient statusCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2025·Application pending·0 cites
- 1266US11662343B2Cellular populations and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2018·Granted May 30, 2023·0 cites·13 claims
- 1366US2025270285A1Methods of treating autoimmune disease using allogeneic t cellsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2025·Application pending·0 cites
- 1464US2022136061A1Treatment and detection of melanomaCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 1563US2021047403A1Immunoreceptor modulation for treating cancer and viral infectionsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 1663US2025134990A1Immunogenic compositions and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 1760US2023192774A1Immunotherapy for polyomavirusesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 1859US2020057068A1Determining a Cancer PrognosisCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Application pending·0 cites
- 1956US2024352072A1Novel compositions and methods for treating coronavirus infectionsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 2055US12429477B2Methods and agents for determining patient statusCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Granted Sep 30, 2025·0 cites·11 claims
- 2155US2026055195A1Targeting epha3 and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 2254US2023173061A1Human cytomegalovirus polyepitope vaccine compositionCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 2353US2023349889A1Methods of Determining Immune ResponseCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 2453US2023181642A1Immune cells with enhanced functionCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 2553US2024117005A1Novel bicyclic peptidesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 2653US2023381298A1Herpesvirus polyepitope vaccinesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 2752US2023210984A1Adoptive immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 2852US2022365089A1Cancer diagnosticCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 2951US12498373B2Glycoprotein biomarkers for esophageal adenocarcinoma and Barrett's esophagus and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Granted Dec 16, 2025·0 cites·15 claims
- 3051US2021220402A1Methods of treating autoimmune disease using allogeneic t cellsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Application pending·0 cites
- 3151US2023348558A1Compositions and methods for targeting hpv-infected cellsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2021·Application pending·0 cites
- 3250US11478508B2Methods of immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Granted Oct 25, 2022·0 cites·19 claims
- 3349US2021380657A1T-Cell Receptors and Uses ThereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 3448US2022135642A1Cells, compositions and methods for enhancing immune functionCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 3547US2022227876A1Rank antagonists and uses thereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 3647US2021046114A1Hpv immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 3747US2022023419A1Inhibiting inflammationCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 3847US2021340629A1Biomarkers for cancer therapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 3947US2022378878A1Treatment of gastrointestinal diseaseCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 4047US2021252128A1Multivirus-specific t cell immunotherapyCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Application pending·0 cites
- 4146US2023040417A1Defective interfering particlesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 4246US2023151438A1Viral detection assayCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 4344US11920158B2Cardiomyocyte maturationCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Granted Mar 5, 2024·0 cites·19 claims
- 4444US2020255499A1Antibody to Epstein Barr Virus and Uses ThereofCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2018·Application pending·0 cites
- 4542US2022187282A1Cardiomyocyte proliferationCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 4642US2022227873A1Anti-gal9 immune-inhibiting binding moleculesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 4742US2022235135A1Activating anti-gal9 binding moleculesCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 4841US2020239937A1Biomarkers for diagnosing conditionsCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2018·Application pending·0 cites
- 4939US2020123198A1Peptide Libraries and Methods of UseCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2017·Application pending·0 cites
- 5039US2022213198A1Method of treatmentCOUNCIL QUEENSLAND INST MEDICAL RES·Filed 2020·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when COUNCIL QUEENSLAND INST MEDICAL RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →